Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CMS
Pharma
Boehringer joins the list of drugmakers suing over the IRA
The company's Eli Lilly-partnered Jardiance will likely make the list of drugs eligible for pricing negotiations, raising the stakes for this suit.
Zoey Becker
Aug 22, 2023 8:01pm
Sen. Sanders warns about price of Eisai, Biogen's Leqembi
Jul 12, 2023 3:05pm
Moody's identifies drugs destined for CMS price negotiations
Mar 30, 2023 9:00am
Biogen, Eisai submit comments opposing CMS' AD coverage draft
Feb 10, 2022 1:07pm
Biogen's Aduhelm pulls in only $3M in 2021
Feb 3, 2022 9:30am
Medicare received majority of comments iffy on Biogen's Aduhelm
Feb 1, 2022 11:34am
